TTC14 activators comprise a novel class of chemical compounds specifically designed to enhance the activity of the TTC14 protein, a member of the tetratricopeptide repeat (TPR) protein family. These activators are of significant interest due to the role of TTC14 in various cellular processes, including protein-protein interactions that are essential for the proper functioning of cellular signaling pathways. The mechanism of action of TTC14 activators involves binding to specific sites on the TTC14 protein, facilitating a conformational change that increases its ability to interact with partner proteins. This enhanced interaction capability can lead to the modulation of signaling pathways in which TTC14 is involved, providing insights into the protein's role in cellular mechanisms. The specificity of these activators towards TTC14 is crucial, as it allows for the targeted exploration of TTC14's functions without interfering with the activity of other TPR proteins or unrelated proteins within the cell. By elucidating the effects of TTC14 activation, researchers can gain a better understanding of the protein's contribution to cellular homeostasis and the regulation of signaling networks.
The identification and optimization of TTC14 activators employ a multi-faceted approach that integrates high-throughput screening (HTS), computational modeling, and experimental validation techniques. Initially, HTS methodologies are used to sift through extensive libraries of chemical compounds to find those capable of enhancing TTC14 activity. Selected hits from these screens are further analyzed using computational tools, such as molecular docking and dynamics simulations, to predict their binding efficiency and orientation with respect to TTC14. Following computational optimization, experimental validation is conducted through biochemical assays to confirm the ability of these compounds to increase the activity of TTC14. Techniques like X-ray crystallography or NMR spectroscopy are also utilized to detail the interaction between TTC14 and the activators, providing a molecular-level understanding of the activation mechanism. Through this integrated approach, TTC14 activators are developed, offering valuable tools for probing the functional roles of TTC14 in cellular signaling and for advancing our knowledge of the regulatory mechanisms that govern protein-protein interactions within the cell.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can regulate gene expression via retinoic acid receptors, possibly affecting TTC14 transcription. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This polyphenol may influence epigenetic modifications, potentially impacting TTC14 gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
This DNA methyltransferase inhibitor may change DNA methylation status, potentially upregulating TTC14 expression. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Vitamin D3, through its receptor, may influence transcriptional activity, possibly affecting TTC14 gene expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
As a glucocorticoid, dexamethasone can regulate numerous genes, which might include TTC14. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane can affect transcription factor activity, which could lead to changes in TTC14 expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
This mTOR inhibitor may alter cellular growth signals, potentially influencing TTC14 expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Sodium valproate, an HDAC inhibitor, may cause histone hyperacetylation affecting TTC14 expression. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol can modulate estrogen receptor-mediated gene expression, potentially influencing TTC14 levels. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium impacts GSK-3 activity, which could have downstream effects on TTC14 gene expression. | ||||||